Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Precise Biometrics signs license agreement with Chipone

Precise Biometrics, the leader in fingerprint software, has entered an agreement with Chipone for licensing of Precise Biometrics’ algorithm solution for fingerprint recognition in mobile devices, Precise BioMatch™ Mobile.The license agreement will generate royalty revenue based on sales of fingerprint sensors from Chipone that includes Precise BioMatch Mobile. Royalty revenues are volume dependant and cannot be forecasted at this point. The agreement includes a limited initial fixed fee for the right to integrate and use Precise Biometrics’ software and for support & maintenance, which

Cxense ASA - Share Capital Increase Resolution

Pursuant to an authorization from the Extraordinary General Meeting in Cxense ASA (the "Company") on 12 October 2015, the Board of Directors of the Company has resolved an issuance of 43,583 new shares to Ramp Holdings, Inc. in connection with the Asset Purchase Agreement completed on 22 October 2015. The share issuance is part of the settlement of the purchase price adjustment mechanism agreed in the Asset Purchase Agreement. Following the issuance, the Company’s share capital is NOK 30,460,270 divided into 6,092,054 shares, each share having a par value of NOK 5. About Cxense

AVTECH appoints a new Chief Executive Officer

The Board of AVTECH Sweden AB (publ) ("AVTECH" and / or "the Company") today announces that the Board of Directors, following discussions initiated by and in full agreement with the company's CEO Christer Staaf, has decided to as of March 1, 2016 change the CEO of Company. Christer Fehrling, since 2007 Board member and one of the major shareholders of the Company, will effective 1 March 2016 assume the position as the Company's new Chief Executive Officer while Christer Staaf will move into an advisory role. Christer Fehrling will be CEO during the time period when a long-term CEO is

Year-end report 2015

JANUARY – DECEMBER 2015- Net sales amounted to SEK 283.2 (187.7) million- EBITDA was SEK 12.8 (-34.1) million- Basic earnings per share were SEK -0.27 (-0.82) OCTOBER – DECEMBER 2015- Net sales amounted to SEK 72.4 (60.3) million- EBITDA was SEK 3.6 (-1.4) million- Basic earnings per share were SEK -0.06 (-0.09)SIGNIFICANT EVENTSSignificant increase in net sales and gross profit during the year- Net sales increased by 51% to SEK 283.2 million- Gross profit increased by 88% to SEK 132.5 million Positive EBITDA of SEK 12.8 million for the year- Strong sales growth

Clavister Partners with NEC and Netcracker for Next-generation Virtualized Networking Solutions

Clavister joins NEC SDN Partner Space and collaborates to accelerate and secure SDN and NFV migrations for service providers and mobile network operatorsClavister (Nasdaq: CLAV), a leader in high-performance network security, has joined the NEC SDN Partner Space ecosystem and is collaborating with NEC and Netcracker, providers of Software Defined Networking (SDN) and Network Function Virtualization (NFV) solutions, business support, and operations support systems.  The collaboration will enable solutions that accelerate and secure deployments of SDN and NFV infrastructures for service

Elos Medtech - Year-end report, 1 January – 31 December 2015

• Net sales amounted to SEK 503.7 M (380.9), up 26.4%, of which organic growth accounted for minus 1.1%*. The unit in Tianjin had a negative impact on growth and the remaining units contributed with a positive growth of 4.9%*. • Order bookings were SEK 472.6 M (418.1), up 8.0%*. Onyx Medical continued to contribute positively to order bookings. The lower demand in Tianjin had a negative impact on the year, this unit’s current workload indicates a return to normal levels. • Operating profit,prior non-recurring items, totalled SEK 38.7 M (36.5). The strong trend for Onyx Medical

Year-end report, 2015 Rabbalshede Kraft AB (publ)

Significant events during the fourth quarter, October 1, 2015 – December 31, 2015 · Production for the fourth quarter totaled 169,975 MWh (158,110) · Net sales totaled KSEK 78,811 (68,047) · EBITDA amounted to KSEK 50,443 (34,154) · The Company posted an operating loss (EBIT) of KSEK 153,711 (profit: 19,152) · The average sales price for wind power production amounted to SEK 472/MWh (478), of which electricity accounted for SEK 286/MWh (303) and electricity certificates and guarantees of origin for SEK 186/MWh (175) · In December, a new share issue was implemented whereby the company earned

Continued growth in 2015

Annual revenue up 14.6%, reaching NOK 374 million, with 9.1% EBIT. Earnings per share nearly tripled to NOK 1.11 compared to fiscal 2014.Zalaris, a leading provider of payroll and HR services, generated solid results for its 2015 fiscal year, continuing to advance the financial performance. The company grew sales 14.6% to NOK 374 million and EBIT of NOK 33.8 million (9.1%) for the period, which ended 31, December 2015. Earnings per share nearly tripled to NOK 1.11 from 0.38 in 2014. “The results for 2015 show continued strong growth for Zalaris. In addition, we experience a promising

ZALARIS: 2015 Fourth Quarter Results

Continued growth in 2015Annual revenue up 14.6%, reaching NOK 374 million, with 9.1% EBIT. Earnings per share nearly tripled to NOK 1.11 compared to fiscal 2014.Zalaris, a leading provider of payroll and HR services, generated solid results for its 2015 fiscal year, continuing to advance the financial performance. The company grew sales 14.6% to NOK 374 million and EBIT of NOK 33.8 million (9.1%) for the period, which ended 31, December 2015. Earnings per share nearly tripled to NOK 1.11 from 0.38 in 2014."The results for 2015 show continued strong growth for Zalaris. In addition, we

Herantis Pharma Plc Financial Statements Release January 1-December 31, 2015

Herantis Pharma Plc's Financial Statements Release January 1 - December 31, 2015 With confidence toward launching new clinical studies Highlights in January-December 2015: · In November, Finnish Medicines Agency Fimea authorized Herantis' first-in-man clinical study of the Lymfactin® for the treatment of breast cancer associated lymphedema. · In June, Tekes, the Finnish Funding Agency for Innovation, granted a R&D loan of €2.903 million to Herantis to support its clinical study of CDNF for the treatment of Parkinson's disease. A Clinical Trial Application was submitted in

SDRL - Seadrill Limited Announces Fourth Quarter 2015 Results

Highlights · Revenue of $959 million · EBITDA of $513 million · 93% economic utilization · Reported Net Income of $279 million and diluted earnings per share of $0.58 · Cash and cash equivalents of $1.04 billion · The Seadrill Group achieved 95% economic utilization · Seadrill Group orderbacklog of approximately $10.7 billion Commenting today, Per Wullf, CEO and President of Seadrill Management Ltd., said: "During the fourth quarter we experienced our best operational quarter of the year, while continuing to reduce our cost base.  Safe and efficient

Orkla ASA: Mandatory notification of trade - options

On 24 February, in connection with Orkla's former management option programme, 172,000 options in Orkla-shares were exercised at a strike price of NOK 42.53 per share.After this transaction, the total number of options issued in Orkla shares under the management option programme is 2,140,000. Orkla owns 358,135 treasury shares. The number of treasury shares has been corrected for shares related to the shares for employees programmes, which mistakenly have not been deducted in 2016.Orkla ASAOslo, 25 February 2016Ref.:Investor RelationsElise HeidenreichTel.: +47 951 41 147This

Life-threatening bowel ischemia can often be treated by balloon angioplasty

Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland. The study also found that AMI is a more common cause of abdominal pain among the elderly than generally thought; however, it is difficult to diagnose before bowel damage develops. If left untreated, acute mesenteric ischemia usually leads to gangrenous bowel, which is a life-threatening condition. AMI usually results from an occlusion of the superior mesenteric artery, typically caused by arteriosclerosis or

D. Carnegie & Co has entered into an agreement regarding repayment of convertible subordinated loans - Reduces dilution and improves financial net

In order to preven dilution of shares due to conversion of convertible subordinated loans in D. Carnegie & Co AB (publ) (the ”Company”) – listed on Nasdaq Stockholm – the Company has entered into a repayment agreement (the “Agreement”) with the creditor, Svensk Bolig Holding AB (“SBH”), on repayment of the subordinated loans. The Company will also pay SBH a market-based compensation for the value of the option. As part of the financing of the repayment, the Company will convene an extraordinary general meeting to authorize an issue of new.In the Company’s acquisition of all the shares in

Starbreeze AB (publ) Year-end report October 1 - December 31 2015

These corporate news are available in Swedish and English.Please find the Year-end report October 1st 2015 – December 31st 2015 attached below:Changed Fiscal Year Note that in accordance with the decision taken on the Annual Shareholders Meeting in November 2015, this will be the last report of the fiscal year 2015/2016. The next report to be issued from Starbreeze will be the First Quarterly Report of 2016 and will be distributed on May 12 2016. · Pressrelease for download: 2016-02-25-Starbreeze Year End Report Q2 2015-2016 

Panoro Energy Announces Fourth Quarter 2015 Results and Provides Operations and Corporate Updates

Thursday, 25 February 2016 - Panoro Energy (Oslo TICKER: PEN) ("Panoro" or the "Company") today announces the fourth quarter 2015 financial results and provides the following updates: · Cash balance of USD 10.9 million as at 31 December 2015 and no debt · Successful Equity Private Placement of new shares with gross proceeds of NOK 70 million during February 2016 (subject to shareholders’ approval); subsequent offering planned for up to NOK 10 million · Production drilling on Aje (Nigeria) Cenomanian oil development completed during Q4 and first oil production targeted for end of

LAFAYETTE 148 NEW YORK CELEBRATES 20TH ANNIVERSARY

WITH 20 YEARS OF WHAT’S NEXTNEW YORK – February 24, 2016 – In honor of their 20th anniversary, leading women’s fashion brand Lafayette 148 New York launches a yearlong campaign celebrating 20 Years of What’s Next.    “We never ask the question ‘What’s New?’ We ask ‘What’s Next?’” says CEO and Co-Founder Deirdre Quinn. “It is the question that has kept the business moving forward since the day we opened 20 years ago. It is the question that drives our technical innovations. And it is the challenge that inspires our design team every day.”   20 Years of What’s Next is the

Aker Solutions ASA: Mandatory Notification of Trade

February 24, 2016 - Aker Solutions ASA today bought 100,000 own shares at an average price of NOK 22.7341 per share. The shares were acquired on the Oslo stock exchange as part of the company's share purchase program for employees. This gives Aker Solutions a new holding of 651,311 own shares. ENDS For further information, please contact: Media:Bunny Nooryani, Chief Communications Officer, Aker Solutions. Tel: +47 67 59 42 71, Mob: +47 480 27 575, E-mail: bunny.nooryani@akersolutions.com Investors:David Phillips, Head of Industry & Investor Relations, Aker Solutions. Tel:

AMETEK ROTRON HIGH OUTPUT ELECTRONIC COOLING FAN OPTIMIZED FOR HEAT SINK AND HEAT EXCHANGER APPLICATIONS

Compact MIL-XTM fans deliver best-in-class airflow capacity Contact: Geoff Levin +1 845-679-1390, geoff.levin@ametek.com WOODSTOCK, NY, USA -- AMETEK Rotron (www.rotron.com) has introduced a high output version of its MIL-XTM Tubeaxial Fan that is optimized for heat sink and heat exchanger electronic cooling applications. This addition to the Extreme Performance Series delivers best-in-class capacity of 450 cfm @ 1" iwg or 350 cfm @ 2" iwg. It is designed for long life in harsh military, aerospace and industrial environments. The new fans can be used to cool electronic devices

Badger Explorer ASA – Q4 2015 Report

Badger Explorer ASA (BXPL) releases its Q4 2015 Report today. The Company's Q4 2015 investor presentation in Oslo will take place at Arctic Securities ASA's premises at Haakon VII's gate 5, 0123 Oslo on Thursday, 25th February 2016 at 11:00 - 12:00 CET. The investor presentation in Stavanger will take place at Badger Explorer ASA's premises at Forusskogen 1, 4033 Stavanger on Friday, 26th February 2016 at 09:00 - 10:00 CET. BXPL and Statoil, the current partners in the Development Program, have continued close and frequent contact to advance the Development Program. Agreed focus areas

United Bankers Oyj : SHARE REPURCHASE 24.2.2016

United Bankers Oyj     STOCK EXCHANGE ANNOUNCEMENT    24.2.2016   SHARE REPURCHASE 24.2.2016   In the Helsinki Stock Exchange     Trade date 24.2.2016Bourse trade BUYShare UNIAVAmount 550 sharesTotal cost 22 176,50 EURAverage price/ share 40,3209 EURHighest price/ share 40,51 EURLowest price/ share 40,00 EUR  United bankers Oyj now holds a total of 934 shares including the shares repurchased on 24.2.2016.   On behalf of United Bankers Oyj   NORDEA

New Product Guide for Hotelympia:

CESA one-off will help equipment buyers find new launches and latest energy-saving technologiesLeading catering equipment brands are featured in a special Hotelympia guide designed to help visitors looking for new launches and specific types of appliances, such as energy–saving models. The CESA New Product Guide includes names like BGL Rieber, Gram, Hobart, Victor, Williams and Winterhalter. As well as listing new models it highlights three characteristics – energy saving, water saving and labour saving – along with each design’s key features and benefits.   The Guide also lists other

There are no items matching the current filter
There are no more items matching the current filter
Back to top